UPDATE: Evercore Downgrades CME to Equal-Weight
According to Evercore Partners, CME Group (NYSE: CME) is downgraded to Equal-Weight.
Evercore Partners said that it is downgrading CME to Equal-Weight from Overweight. “We have also lowered our price target to $250 (14x our 2012 estimate, and 7% upside from current levels).”
CME Group closed on Friday at $234.







